- Home
- RARE vs CARG Comparison
RARE vs CARG Comparison
Compare RARE & CARG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RARE
- CARG
- Stock Information
- Founded
- RARE 2010
- CARG 2005
- Country
- RARE United States
- CARG United States
- Employees
- RARE N/A
- CARG N/A
- Industry
- RARE Biotechnology: Pharmaceutical Preparations
- CARG EDP Services
- Sector
- RARE Health Care
- CARG Technology
- Exchange
- RARE Nasdaq
- CARG Nasdaq
- Market Cap
- RARE 3.1B
- CARG 3.2B
- IPO Year
- RARE 2014
- CARG 2017
- Fundamental
- Price
- RARE $33.28
- CARG $35.99
- Analyst Decision
- RARE Strong Buy
- CARG Buy
- Analyst Count
- RARE 13
- CARG 13
- Target Price
- RARE $87.69
- CARG $39.12
- AVG Volume (30 Days)
- RARE 1.5M
- CARG 931.3K
- Earning Date
- RARE 11-03-2025
- CARG 11-06-2025
- Dividend Yield
- RARE N/A
- CARG N/A
- EPS Growth
- RARE N/A
- CARG N/A
- EPS
- RARE N/A
- CARG 1.24
- Revenue
- RARE $610,159,000.00
- CARG $919,087,000.00
- Revenue This Year
- RARE $19.72
- CARG $6.25
- Revenue Next Year
- RARE $23.29
- CARG $5.86
- P/E Ratio
- RARE N/A
- CARG $28.79
- Revenue Growth
- RARE 26.77
- CARG 4.79
- 52 Week Low
- RARE $25.81
- CARG $24.65
- 52 Week High
- RARE $56.38
- CARG $41.33
- Technical
- Relative Strength Index (RSI)
- RARE 58.42
- CARG 52.52
- Support Level
- RARE $32.40
- CARG $34.91
- Resistance Level
- RARE $34.78
- CARG $35.93
- Average True Range (ATR)
- RARE 1.26
- CARG 1.08
- MACD
- RARE 0.27
- CARG -0.01
- Stochastic Oscillator
- RARE 71.21
- CARG 52.08
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About CARG CarGurus Inc.
CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. The company provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.